Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 121.58 -0.01 (-0.01%) Market Cap: 7.35 Bil Enterprise Value: 10.93 Bil PE Ratio: 17.12 PB Ratio: 1.76 GF Score: 85/100

Jazz Pharmaceuticals PLC at Jefferies London Healthcare Conference Transcript

Nov 21, 2019 / 10:40AM GMT
Release Date Price: $142.63 (+1.41%)
David Michael Steinberg
Jefferies LLC, Research Division - Specialty Pharma Analyst

Good morning, everyone. We're delighted to have with us the management of Jazz Pharmaceuticals from sunny Palo Alto, California. I'm Dave Steinberg, Specialty Pharma Analyst at Jefferies. So we're going to do a fireside chat, which is a much better way to delve into all the questions. With me is Dan Swisher, President and Chief Operating Officer of Jazz. So Dan, welcome, and thanks for coming all the way from California.

Daniel N. Swisher
Jazz Pharmaceuticals plc - President & COO

Thank you.

Questions & Answers

David Michael Steinberg
Jefferies LLC, Research Division - Specialty Pharma Analyst

Let me start right at the top. Can you share your vision of where you think Jazz is going for the next 5 years?

Daniel N. Swisher
Jazz Pharmaceuticals plc - President & COO

Sure. And I just like to also introduce my colleagues, Kathee Littrell, Head of IR; and Hugh Kiely, who's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot